| Prev Close: | 20.00 |
|---|---|
| Open: | 19.99 |
| Bid: | 19.07 x 500 |
| Ask: | 20.27 x 500 |
| 1y Target Est: | 20.83 |
| Beta: | 1.37 |
| Next Earnings Date: | 31-Jul-13 |
| Day's Range: | 19.58 - 20.00 |
|---|---|
| 52wk Range: | 10.85 - 20.75 |
| Volume: | 11,448,799 |
| Avg Vol (3m): | 6,633,690 |
| Market Cap: | 5.01B |
| P/E (ttm): | 12.40 |
| EPS (ttm): | 1.61 |
| Div & Yield: | 0.50 (2.60%) |
Quotes delayed, except where indicated otherwise. Currency in USD.
Headlines
- [$$] Bausch & Lomb Nears $9 Billion Saleat The Wall Street Journal(Fri, May 24)
- Valeant Stock Spikes On Possible Bausch & Lomb Dealat Investor's Business Daily(Fri, May 24)
- Acquisition-hungry Valeant sets its sights on Bausch & Lomb: reportat MarketWatch(Fri, May 24)
- Valeant near deal to acquire Bausch & Lomb: sourceat Reuters(Fri, May 24)
- Valeant near deal to acquire Bausch & Lomb -sourceat Reuters(Fri, May 24)
- Value Investor Joel Greenblatt's Magically Cheap Stock Picksat Seeking Alpha(Fri, May 24)
- Actavis Buys Warner Chilcott, Upside Seems Limitedat Seeking Alpha(Fri, May 24)
- Actavis To Increase Operational Synergies By Acquiring Warnerat Seeking Alpha(Fri, May 24)
- Warner Chilcott Stock Falls On Unusually High Volume (WCRX)at TheStreet(Wed, May 22)
- The Zacks Analyst Blog Highlights: Actavis, Warner Chilcott, Bill Barrett, Linn Energy and Forest OilZacks(Wed, May 22)
- Kasowitz Benson, Eversheds, Latham: Business of Lawat Bloomberg(Wed, May 22)
- After the close: Merck's mysterious gain; Warner and Actavis stay upat MarketWatch(Tue, May 21)
- Actavis Lowers Tax Rate to 17% After Warner Chilcott Dealat Bloomberg(Tue, May 21)
- Actavis to Buy Warner ChilcottZacks(Tue, May 21)
- The Deal: Actavis Extends Gains Following Warner Dealat TheStreet(Tue, May 21)
Press Releases
- Announcement Under Irish Takeover Rules Revision to Relevant Securities in IssueGlobeNewswire(Mon, May 20)
- Actavis to Acquire Warner Chilcott to Create Premier $11 Billion Revenue Global Specialty Pharmaceutical CompanyPR Newswire(Mon, May 20)
- Announcement Under Irish Takeover Rules Relevant Securities in IssueGlobeNewswire(Mon, May 13)
Reports
- ValuEngine Industry Report for Medical-drugsValuEngine, Inc.(May 24)
- WCRX - Warner Chilcott Plc - Upgraded to a Buy - Company Analysis and ASR Ranking...Alpha Street Research(May 24)
- ValuEngine Detailed Valuation Report for WCRXValuEngine, Inc.(May 23)